e-learning
resources
Vienna 2009
Monday, 14.09.2009
Tuberculosis: metabolism and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidities – risk factors for relapsed pulmonary TB
M. Popescu-Hagen, M. Mihailescu, D. Bica, C. Didilescu, M. Tanasescu, B. Mahler, C. Marica (Bucharest, Craiova, Romania)
Source:
Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Session:
Tuberculosis: metabolism and comorbidities
Session type:
Thematic Poster Session
Number:
2557
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Popescu-Hagen, M. Mihailescu, D. Bica, C. Didilescu, M. Tanasescu, B. Mahler, C. Marica (Bucharest, Craiova, Romania). Comorbidities – risk factors for relapsed pulmonary TB. Eur Respir J 2009; 34: Suppl. 53, 2557
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Pulmonary TB -diabetes melitus – an unfavorable association
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Risk factors for pulmonary
Mycobacterium avium-intracellulare
complex disease deterioration in immunocompetent patients
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Arterial thromboembolic complications in patients with lung cancer – Impact on survival
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids?
Source: International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases
Year: 2014
Prevalence of chronic obstructive lung disease (COPD) in a industrial environment – the impact of occupational risk factors
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Risk factors for severe bronchiolitis – A retrospective study
Source: Annual Congress 2012 - Paediatric respiratory epidemiology. Wheeze: where, how and why?
Year: 2012
Predictors of PAO
2
and PaCO
2
in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Comorbidities, hospitalizations and the risk for readmission after AE COPD – Longitudinal study
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
The assessment of risk factors and treatment of pulmonary TB relapses
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006
Analysis of prevalence of depression in patients with tuberculosis and pneumonia – Is depression consequance only in chronic clinical failure ?
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010
Chronic kidney disease (CKD) – A forgotten co-morbidity in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Pulmonary tuberculosis presentation – Late diagnosis, advanced disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Tuberculosis – An important risk factor for lung cancer
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Breathlessness on bending down in COPD patients – prevalence and predictors
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Risk factors for tuberculosis in patients with chronic alcoholism
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Impaired pulmonary function and the risk of tuberculosis – A population based cohort study
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept